As such, compared to WT, a direct reader of m6A, Ythdf1 KO mice showed better cross-presentation of tumor antigens in DC and better cross-priming with CD8+ T cells, leading to high Ag-specific CD8+ T cells in response to tumors [122]. The gene discussed is CD8A; the disease is neoplasm.